Indi Molecular, an emerging life sciences company, has raised $11.5 million in financing. The investors included M Ventures, Legend Capital, Sabey Corporation and Asset Management Ventures. In addition to the funding, Dr. Andreas Jurgeit from Merck Ventures and Dr. Darren Cai from Legend Capital will join Indi Molecular's board.